Recent research challenges long-standing assumptions about how ADHD medications work. A study led by Benjamin Kay and Nico Dosenbach at Washington University School of Medicine found that prescription stimulants such as Ritalin and Adderall may not directly improve attention as previously believed. Instead, these drugs primarily enhance brain systems related to arousal, wakefulness, and reward, indirectly boosting focus in children with ADHD.
The study, published in Cell on December 24, 2025, analyzed resting-state fMRI data from 5,795 children aged 8–11 who participated in the Adolescent Brain Cognitive Development (ABCD) Study. Children who had taken stimulants showed heightened activity in brain regions associated with alertness and motivation, but not in traditional attention networks. Follow-up tests in adults confirmed similar patterns.
Dosenbach explained, “Stimulants pre-reward our brains, allowing us to stick with tasks that might not normally hold our interest. This helps children focus because the tasks feel more rewarding.” This mechanism also helps reduce hyperactivity, as previously unrewarding activities are now more engaging.
The findings highlight the interplay between medication and sleep quality. Children with ADHD who were sleep-deprived showed notable improvements in grades and cognitive tests when taking stimulants. However, stimulants did not enhance performance in well-rested neurotypical children. Researchers caution that relying on medication to offset chronic sleep deprivation could have long-term consequences, underscoring the importance of addressing sleep in ADHD management.
The study suggests a paradigm shift: ADHD medications work more by waking up the brain and increasing engagement rather than directly sharpening attention, offering new insights into personalized treatment approaches.
